BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17119116)

  • 41. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women].
    Liao YP; Bao MS; Liu CQ; Liu H; Zhang D
    Yi Chuan; 2010 May; 32(5):461-6. PubMed ID: 20466634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer.
    Murtaugh MA; Curtin K; Sweeney C; Wolff RK; Holubkov R; Caan BJ; Slattery ML
    Cancer Causes Control; 2007 Mar; 18(2):153-63. PubMed ID: 17245555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study.
    Polesel J; Talamini R; Montella M; Parpinel M; Dal Maso L; Crispo A; Crovatto M; Spina M; La Vecchia C; Franceschi S
    Ann Oncol; 2006 Apr; 17(4):713-8. PubMed ID: 16556850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms in folate metabolism as risk for Down syndrome in the southern China.
    Jiajin L; Shuyan C; Ying W; Junxiao C; Xiudi W
    J Matern Fetal Neonatal Med; 2019 Jun; 32(12):2030-2035. PubMed ID: 29343135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.
    Steck SE; Keku T; Butler LM; Galanko J; Massa B; Millikan RC; Sandler RS
    J Nutrigenet Nutrigenomics; 2008; 1(4):196-204. PubMed ID: 19776626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan.
    Ma E; Iwasaki M; Kobayashi M; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Tsugane S
    Nutr Cancer; 2009; 61(4):447-56. PubMed ID: 19838916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folate-related nutrients, genetic polymorphisms, and colorectal cancer risk: the fukuoka colorectal cancer study.
    Morita M; Yin G; Yoshimitsu S; Ohnaka K; Toyomura K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
    Asian Pac J Cancer Prev; 2013; 14(11):6249-56. PubMed ID: 24377513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.
    Kelly JL; Drake MT; Fredericksen ZS; Asmann YW; Liebow M; Shanafelt TD; Feldman AL; Ansell SM; Macon WR; Herr MM; Wang AH; Nowakowski GS; Call TG; Habermann TM; Slager SL; Witzig TE; Cerhan JR
    Cancer Causes Control; 2012 Jul; 23(7):1017-29. PubMed ID: 22544453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
    Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
    Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer.
    Ulrich CM; Curtin K; Potter JD; Bigler J; Caan B; Slattery ML
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2509-16. PubMed ID: 16284371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan.
    Otani T; Iwasaki M; Hanaoka T; Kobayashi M; Ishihara J; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Yoshimura K; Yoshida T; Tsugane S
    Nutr Cancer; 2005; 53(1):42-50. PubMed ID: 16351505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States).
    Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Hebert JR; Coker A; Wargovich M
    Cancer Causes Control; 2004 Jun; 15(5):493-501. PubMed ID: 15286469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-Hodgkin lymphoma.
    Smedby KE; Eloranta S; Duvefelt K; Melbye M; Humphreys K; Hjalgrim H; Chang ET
    Am J Epidemiol; 2011 Jan; 173(1):48-54. PubMed ID: 21076051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study.
    Kelemen LE; Cerhan JR; Lim U; Davis S; Cozen W; Schenk M; Colt J; Hartge P; Ward MH
    Am J Clin Nutr; 2006 Jun; 83(6):1401-10. PubMed ID: 16762953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma.
    Chiu BC; Dave BJ; Ward MH; Fought AJ; Hou L; Jain S; Gapstur S; Evens AM; Zahm SH; Blair A; Weisenburger DD
    Cancer Causes Control; 2008 Oct; 19(8):859-67. PubMed ID: 18386141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
    Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
    Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
    Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.